Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …
Next generation antibody drugs: pursuit of the'high-hanging fruit'
PJ Carter, GA Lazar - Nature Reviews Drug Discovery, 2018 - nature.com
Antibodies are the most rapidly growing drug class and have a major impact on human
health, particularly in oncology, autoimmunity and chronic inflammatory diseases. Many of …
health, particularly in oncology, autoimmunity and chronic inflammatory diseases. Many of …
Oncolytic viruses in cancer treatment: a review
Importance Oncolytic viruses (OVs) are emerging as important agents in cancer treatment.
Oncolytic viruses offer the attractive therapeutic combination of tumor-specific cell lysis …
Oncolytic viruses offer the attractive therapeutic combination of tumor-specific cell lysis …
Targeting co-stimulatory molecules in autoimmune disease
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …
The promise and challenges of immune agonist antibody development in cancer
PA Mayes, KW Hance, A Hoos - Nature Reviews Drug Discovery, 2018 - nature.com
Immune cell functions are regulated by co-inhibitory and co-stimulatory receptors. The first
two generations of cancer immunotherapy agents consist primarily of antagonist antibodies …
two generations of cancer immunotherapy agents consist primarily of antagonist antibodies …
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy
Antibodies targeting costimulatory receptors of T cells have been developed for the
activation of T cell immunity in cancer immunotherapy. However, costimulatory molecule …
activation of T cell immunity in cancer immunotherapy. However, costimulatory molecule …
[HTML][HTML] Biological drug and drug delivery-mediated immunotherapy
The initiation and development of major inflammatory diseases, ie, cancer, vascular
inflammation, and some autoimmune diseases are closely linked to the immune system …
inflammation, and some autoimmune diseases are closely linked to the immune system …
Multifunctional Au Modified Ti3C2-MXene for Photothermal/Enzyme Dynamic/Immune Synergistic Therapy
Ti3C2-MXene-based composites provide multifunctional interfaces in diagnosis and
treatment of tumors. Herein, we proposed a multifunctional nanoplatform based on Ti3C2 …
treatment of tumors. Herein, we proposed a multifunctional nanoplatform based on Ti3C2 …
Immunotherapy in renal cell carcinoma: the future is now
Renal cell carcinoma is the third type of urologic cancer and has a poor prognosis with 30%
of metastatic patients at diagnosis. The antiangiogenics and targeted immunotherapies led …
of metastatic patients at diagnosis. The antiangiogenics and targeted immunotherapies led …